Stock Events

Bonesupport Holding AB 

SEK193.9
2
-SEK1.8-0.92% Today

Statistics

Day High
-
Day Low
-
52W High
-
52W Low
-
Volume
-
Avg. Volume
-
Mkt Cap
5.15B
P/E Ratio
-
Dividend Yield
-
Dividend
-

Earnings

13JulConfirmed
Q2 2020
Q3 2020
Q3 2020
Q4 2020
Q1 2021
Q2 2021
Q2 2022
-0.25
-0.17
-0.08
0
Expected EPS
N/A
Actual EPS
-0.25

People Also Follow

This list is based on the watchlists of people on Stock Events who follow BONEX.ST. It's not an investment recommendation.

About

Bonesupport Holding AB (publ), an orthobiologics company, develops and commercializes injectable bioceramic bone graft substitutes for the treatment of bone voids in Europe, North America, and internationally. The company provides CERAMENT Bone Void Filler, an injectable, moldable, and drillable synthetic bone void filler that includes hydroxyapatite, calcium sulfate, and the radio-contrast agent iohexol; CERAMENT G, a gentamicin injectable ceramic bone graft substitute; and CERAMENT V, a vancomycin injectable synthetic bone void filler. It also develops preclinical product candidates to promote bone regrowth focusing on trauma, revision arthroplasty, chronic osteomyelitis, revision artroplasty, and oncology, as well as bone and foot infections due to diabetes. The company was founded in 1999 and is headquartered in Lund, Sweden.
Show more...
CEO
Mr. Emil Billbäck
Employees
86
Country
Sweden
ISIN
SE0009858152
WKN
000A2DTSD

Listings